Understanding and targeting inflammation in brain injuries
Mechanisms and Therapeutic Targeting of Chronic Neuroinflammation in Traumatic Brain Injury
This study is looking at how a traumatic brain injury can cause ongoing brain inflammation that might lead to memory and thinking problems, and it aims to find new treatments that could help people who have experienced a TBI.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Augusta University NIH-funded |
| Lab location | 1 site (Augusta, United States) |
| Project ID | NIH-11125961 on NIH RePORTER |
What this research studies
This research investigates the long-term effects of traumatic brain injury (TBI) on the brain, focusing on chronic neuroinflammation that can lead to cognitive decline and neurodegeneration. The study aims to identify the mechanisms behind this inflammation, particularly the role of harmful A1 astrocytes, which can damage brain cells. By exploring potential therapies that target these astrocytes, the research seeks to develop new treatment strategies for individuals affected by TBI. Patients may be involved in trials testing these therapeutic interventions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced a traumatic brain injury and are experiencing ongoing cognitive issues.
Not a fit: Patients with brain injuries that occurred a long time ago and who are not experiencing any cognitive decline may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve recovery and cognitive function in patients with traumatic brain injuries.
How similar studies have performed: Other research has shown promise in targeting neuroinflammation in brain injuries, suggesting that this approach could lead to significant advancements in treatment.
Where this research is happening
Augusta, United States
- Augusta University — Augusta, United States (Active)
Researchers
- Principal investigator: Brann, Darrell W — Augusta University
- Study coordinator: Brann, Darrell W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.